These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17259469)

  • 1. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management.
    Grant R; Adams AS; Trinacty CM; Zhang F; Kleinman K; Soumerai SB; Meigs JB; Ross-Degnan D
    Diabetes Care; 2007 Apr; 30(4):807-12. PubMed ID: 17259469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis.
    Ruiz-Negrón N; Wander C; McAdam-Marx C; Pesa J; Bailey RA; Bellows BK
    J Manag Care Spec Pharm; 2019 Mar; 25(3):304-313. PubMed ID: 30816810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence and racial differences in A1C control.
    Adams AS; Trinacty CM; Zhang F; Kleinman K; Grant RW; Meigs JB; Soumerai SB; Ross-Degnan D
    Diabetes Care; 2008 May; 31(5):916-21. PubMed ID: 18235050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refill adherence to oral hypoglycemic agents and glycemic control in veterans.
    Kim N; Agostini JV; Justice AC
    Ann Pharmacother; 2010 May; 44(5):800-8. PubMed ID: 20388863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication Regimen Complexity and A1C Goal Attainment in Underserved Adults With Type 2 Diabetes.
    Yeh A; Shah-Manek B; Lor KB
    Ann Pharmacother; 2017 Feb; 51(2):111-117. PubMed ID: 28042735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antidiabetic medication adherence and glycemic control in managed care.
    Rozenfeld Y; Hunt JS; Plauschinat C; Wong KS
    Am J Manag Care; 2008 Feb; 14(2):71-5. PubMed ID: 18269302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal effects of medication nonadherence on glycemic control.
    Egede LE; Gebregziabher M; Echols C; Lynch CP
    Ann Pharmacother; 2014 May; 48(5):562-70. PubMed ID: 24586059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Rotunno T; Khoan J; Hirsch JD
    Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study.
    Mathur R; Farmer RE; Eastwood SV; Chaturvedi N; Douglas I; Smeeth L
    PLoS Med; 2020 May; 17(5):e1003106. PubMed ID: 32413037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD).
    McEwen LN; Bilik D; Johnson SL; Halter JB; Karter AJ; Mangione CM; Subramanian U; Waitzfelder B; Crosson JC; Herman WH
    Diabetes Care; 2009 Jun; 32(6):971-6. PubMed ID: 19228862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.
    Pantalone KM; Wells BJ; Chagin KM; Ejzykowicz F; Yu C; Milinovich A; Bauman JM; Kattan MW; Rajpathak S; Zimmerman RS
    Diabetes Care; 2016 Sep; 39(9):1527-34. PubMed ID: 27519447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study.
    Buysman EK; Liu F; Hammer M; Langer J
    Adv Ther; 2015 Apr; 32(4):341-55. PubMed ID: 25832470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.
    Blonde L; Wogen J; Kreilick C; Seymour AA
    Diabetes Obes Metab; 2003 Nov; 5(6):424-31. PubMed ID: 14617228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and Clinical Outcomes of Treatment Intensification in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting.
    Kallenbach L; Shui AM; Cheng WY; Fan T; Hu W; Zichlin ML; Duh MS; Ye F; Levin PA
    Endocr Pract; 2018 Sep; 24(9):805-814. PubMed ID: 29975575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do patient or provider characteristics impact management of diabetes?
    LeBlanc ES; Rosales AG; Kachroo S; Mukherjee J; Funk KL; Nichols GA
    Am J Manag Care; 2015 Sep; 21(9):597-606. PubMed ID: 26618363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the relationship between diabetes treatment intensification and quality measure performance using electronic medical records.
    Arnold RJG; Yang S; Gold EJ; Farahbakhshian S; Sheehan JJ
    PLoS One; 2018; 13(6):e0199011. PubMed ID: 29894495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital.
    Ayele AA; Tegegn HG; Ayele TA; Ayalew MB
    BMJ Open Diabetes Res Care; 2019; 7(1):e000685. PubMed ID: 31321061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification?
    Katon W; Russo J; Lin EH; Heckbert SR; Karter AJ; Williams LH; Ciechanowski P; Ludman E; Von Korff M
    Psychosom Med; 2009 Nov; 71(9):965-72. PubMed ID: 19834047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonadherence to insulin therapy in low-income, type 2 diabetic patients.
    Lerman I; Díaz JP; Ibarguengoitia ME; Pérez FJ; Villa AR; Velasco ML; Cruz RG; Rodrigo JA
    Endocr Pract; 2009; 15(1):41-6. PubMed ID: 19211396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States.
    Durden E; Lenhart G; Lopez-Gonzalez L; Hammer M; Langer J
    J Med Econ; 2016; 19(4):403-13. PubMed ID: 26653068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.